The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI). Lengthy drug development timelines and complex regulatory hurdles ...

2024 was pivotal for UK Life Sciences’ venture funding landscape. Softening macro and geopolitical conditions saw activity rebound, setting the stage for an upwards trajectory in 2025. Our recent Life ...

Uruguay's cost of capital reflects institutional choices: keeping inflation down, political stability, honoring contracts and ...

A startup is often rooted in something deeply personal. That was the case for Jiaxin Zhang, an entrepreneur and 2025 MBA graduate of Columbia Business School. Growing up as an immigrant, Zhang endured ...

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, ...

From cancer to Alzheimer’s: could a renewed focus on energy transform biomedicine? Including energy dynamics in research could improve our understanding of diseases and of the healing processes that ...

Mar. 18, 2026 Your morning coffee or tea could be quietly supporting your brain health. A long-term study found that moderate consumption of caffeinated coffee or tea was linked to an 18% lower risk ...